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Background: Systemic inflammation plays an important role in the initiation, promotion, and progression of lung
carcinogenesis. In patients with non-small cell lung cancer (NSCLC), fibrinogen levels correlate with neoplasia. Here
we compared the effects of pulmonary rehabilitation (PR) with chest physical therapy (CPT) on fibrinogen and
albumin levels in patients with LC and previous inflammatory lung disease awaiting lung resection.
Methods: We conducted a randomized clinical trial with 24 patients who were randomly assigned to Pulmonary
Rehabilitation (PR) and Chest Physical Therapy (CPT) groups. Each group underwent training 5 days weekly for
4 weeks. All patients were assessed before and after four weeks of training through clinical assessment,
measurement of fibrinogen and albumin levels, spirometry, 6-minute Walk Test (6MWT), quality of life survey, and
anxiety and depression scale. PR involved strength and endurance training, and CPT involved lung expansion
techniques. Both groups attended educational classes.
Results: A mixed between-within subjects analysis of variance (ANOVA) revealed a significant interaction between
time (before and after intervention) and group (PR vs. CPT) on fibrinogen levels (F(1, 22) = 0.57, p < 0.0001) and a
significant main effect of time (F(1, 22) = 0.68, p = 0.004). Changes in albumin levels were not statistically significant
relative to the interaction effect between time and group (F(1, 22) = 0.96, p = 0.37) nor the main effects of time
(F(1, 22) = 1.00, p = 1.00) and group (F(1, 22 ) = 0.59, p = 0.45). A mixed between-within subjects ANOVA revealed
significant interaction effects between time and group for the peak work rate of the unsupported upper limb
exercise (F(1, 22) = 0.77, p = 0.02), endurance time (F(1, 22) = 0.60, p = 0.001), levels of anxiety (F(1, 22) = 0.60, p = 0.002)
and depression (F(1, 22) = 0.74, p = 0.02), and the SF-36 physical component summary (F(1, 22) = 0.83, p = 0.07).
Conclusion: PR reduced serum fibrinogen levels, improved functional parameters, and quality of life of patients with
LC and inflammatory lung disease awaiting lung resection.
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Malignant neoplasms and chronic degenerative diseases
replace infectious and parasitic pathologies as the main
causes of death in Brazil as well as worldwide, particu-
larly in the United States and Europe [1]. Lung cancer
(LC) is one of the most common malignant neoplasms,
the number of cases continues to increase by 3% annu-
ally [2], and it will become the fifth most frequently di-
agnosed cancer in Brazilian [3].
Surgery without adjuvant treatment is most frequently
indicated to treat patients with early stages (I and II) of
non-small cell lung cancer (NSCLC) [4], and surgery for
patients with up to stage III may be more beneficial
compared with other modalities [1,4]. Systemic inflamma-
tion plays an important role in the initiation, promotion,
and progression of lung carcinogenesis [5]. In patients
with NSCLC there is a relationship between fibrinogen
levels and neoplasia. This is because >50% of patients with
primary tumors and 90% of those with metastases present
with altered coagulation—a prothrombotic state caused by
the ability of cancer cells to activate the coagulation sys-
tem [5-7]. Moreover, serum fibrinogen and albumin levels
serve as prognostic factors for postoperative complications
after lung resection [7,8].
Few studies assessed the impact of pulmonary rehabili-
tation on postoperative complications of patients who
undergo lung resection for lung cancer [9-11], One of
the postoperative outcomes observed by Morano et al.
[11] was that in the PR group, fewer patients developed
bronchopleural fistulas and required a chest tube for a
fewer number of days. However, none of these studies
used a randomized design to assess the influence of pul-
monary rehabilitation on the serum levels of fibrinogenPatients randomized (n=24
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Figure 1 Flow diagram of the randomized clinical trial of a 4-week pu
cancer resection.and albumin. Therefore, to address this important issue,
we assessed the immediate effects of PR versus CPT on
serum levels of fibrinogen and albumin in patients with
NSCLC awaiting lung resection.
Methods
Study design and patients
We conducted a randomized clinical trial in two tea-
ching hospitals in Fortaleza, Northeastern Brazil. The
study included patients with NSCLC who were eligible
for lung resection and experienced previous pulmonary
disease with impaired respiratory function identified using
spirometry. After selection, six groups of four patients
each were randomly assigned (individual allocations were
placed using sealed envelopes) to either the Pulmonary
Rehabilitation (PR, three groups) or the Chest Physical
Therapy (CPT, three groups) groups. Training was con-
ducted five times weekly for 4 weeks. After receiving ap-
proval from the Ethics Committee of the Hospital de
Messejana (Opinion No. 540/80), all subjects granted their
informed written consent.
Enrollment
Thirty-one patients were recruited between March 2008
and March 2011, and seven patients were excluded, be-
cause five refused to participate and two did not meet
inclusion criteria because of normal pulmonary function.
Twenty-four patients were randomly assigned (12 each)
to the PR and 12 CPT groups (Figure 1).
Characterization of patients
Before and after training, all participants were assessed
demographically and clinically (sex, age, weight, height,)
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lung cancer staging), as well as by laboratory analysis of
serum levels of fibrinogen and albumin and by pulmon-
ary function tests. Physical capacity, quality of life, levels
of anxiety, and depression were also assessed. Serum
levels of fibrinogen and albumin were measured using a
blood sample collected in disposable Vacutainer tubes
[12,13]. Pulmonary function was assessed using spirom-
etry following international guidelines [14] with refer-
ence values for the Brazilian population [15]. Normal
lung function was defined using the spirometric parame-
ters as follows: Ratio of forced expiratory volume (FEV1)
to forced vital capacity (FVC) ratio >0.70 and FVC and
FEV1 > 80% of the predicted value. Physical capacity was
measured using the following tests: unsupported upper
limb exercise test (UULEX), endurance testing, and the
6-min walk test (6MWT). The 6MWT was performed
twice over a 30-m corridor according to the American
Thoracic Society (ATS) guidelines [16,17]. Quality of life
was assessed using the Medical Outcomes Study 36 - Item
Short Form Health Survey (SF-36) [18], which comprises
36 items divided into eight domains. The SF-36 results
were grouped for the development of the Physical Com-
ponent Summary (PCS) and the Mental Component Sum-
mary (MCS). The levels of anxiety and depression were
determined using the Hospital Anxiety and Depression
Scale (HADS) [19], which asks 14 questions divided into
anxiety (HDAS-A) and depression (HADS-D) scales.
Interventions
The group of patients undergoing PR was submitted
to upper limb (UL) and lower limb (LL) stretching exer-
cises, warm-up exercises, UL strengthening exercises, aer-
obic conditioning, and inspiratory muscle training. UL
strengthening started at 50% of peak work capacity during
preliminary testing, and it was performed using Proprio-
ceptive Neuromuscular Facilitation (PNF) diagonal move-
ments with barbells. Aerobic conditioning was performed
on a treadmill at 80% of peak work capacity determined
by endurance testing. The group of patients who under-
went CPT followed the routine protocol of the hospital
comprising lung expansion techniques (sustained max-
imum inspiration, fractional inspiration, breathing pat-
terns, pursed lip breathing, and use of a flow-based
incentive spirometer (Respiron®, NCS, Brazil). Both groups
attended educational sessions informing them of the im-
portance of pre- and postoperative care, the surgical
process, energy conservation techniques, as well as relax-
ation, stress, and nutritional management techniques.
Statistical analysis
Data analysis was performed using the Statistical Package
for the Social Sciences 13.0 and GraphPad Prism 5.0. The
Kolmogorov-Smirnov test was used to test for normality.Data are presented as absolute or relative frequency, or
both, represented by the mean ± standard deviation of
normally distributed data or median (interquartile inter-
val) for data not normally distributed. The variation (delta)
between pre- and postoperative periods is presented
as the mean (confidence interval, CI 95%). The Mann–
Whitney U test was used to compare continuous variables
between the two groups at baseline. The values of con-
tinuous variables as a function of time were compared be-
tween groups using a mixed between-within subjects
ANOVA. P <0.05 indicates statistical significance.
Results
All 24 participants successfully completed the training
assignments. Nineteen patients were diagnosed with chro-
nic obstructive pulmonary disease (COPD), two with in-
terstitial lung disease, and three with bronchiectasis. Their
characteristics are presented in Table 1.
Both groups comprised mostly women, older people,
smokers, and patients with Stage I or II lung cancer. The
two groups were equivalent regarding the presence of
COPD and severity of the disease. Of the patients in the
PR and CPT groups, 50% and 60% were classified as Stage
III of the Global Initiative for Chronic Obstructive Lung
Disease, respectively (p = 0.1). The groups did not differ
systematically at the outset.
Fibrinogen levels before and after each intervention
are presented in Figure 2A. A mixed between-within
subjects ANOVA revealed a statistically significant inter-
action effect between time (before and after intervention)
and group (PR vs. CPT) (F(1, 22) = 0.57, p < 0.0001) and a
statistically significant main effect for time (F(1, 22) = 0.68,
p = 0.004). The main effect for group was not statistically
significant (F(1, 22) = 0.41, p = 0.53). Albumin levels before
and after each intervention are presented in Figure 2B.
Neither the interaction effect between time and group
(F(1, 22) = 0.96, p = 0.37) nor the main effects of time
(F(1, 22) = 1.00, p = 1.00) and group (F(1, 22) = 0.59,
p = 0.45) was statistically significant.
Table 2 presents baseline and 1-month physical ca-
pacity, quality of life, anxiety, and depression for each
group. A mixed between-within subjects ANOVA re-
vealed statistically significant interaction effects between
time and group for the peak work rate of the UULEX
(F(1, 22) = 0.77, p = 0.02), endurance time (F(1, 22) = 0.60,
p = 0.001), and the levels of anxiety (F(1, 22) = 0.60,
p = 0.002) and depression (F(1, 22) = 0.74, p = 0.02)
measured using the HADS. The SF-36 physical com-
ponent summary results were not statistically significant
(F(1, 22) = 0.83, p = 0.07). The values of the SF-36 mental
component summary or the 6 min walking were not sta-
tistically significant for interaction effects between time
and group (F(1, 22 ) = 0.98, p = 0.59) and (F(1,22) = 0.08,
p = 0.59, respectively).
Table 1 Baseline characteristics of the participants
Variable PR (n = 12) CPT (n = 12) P
Sex (M/F)* 4/8 5/7 0.46
Age (years)mean ± standard deviation† 65 ± 8 69 ± 7 0.33
BMI (kg · m−2) mean ± standard deviation 26 ± 5 24 ± 6 0.56
Current smoker (n/%)* 10/83 9/75 0.44
Comorbidity (n/%)* 7/58 4/33 0.35
With COPD (n/%)* 9/75 10/83 0.62
LC stage (n/%)*
Stage I/II 11/92 9/75 0.16
Stage III A 1/8 3/25
Lung function
FEV1 (%)mean ± standard deviation† 48 ± 14 49 ± 12 0.41
FVC (%)median(25%-75%)‡ 63 (53 – 93) 63 (50 – 71) 0.26
FEV1/FVC (%)median(25%-75%)‡ 62 (51 – 73) 56 (53 – 61) 0.71
Arterial blood gas
PaCO2 41.8 ± 3.8 42.5 ± 3.6 0.3
PaO2 75.8 ± 5.8 79.9 ± 1.8 0.2
Fibrinogen (mg/dl) median (25%-75%)‡ 414 (366 – 588) 368 (318 – 527) 0.31
Albumin (g/dl) mean ± standard deviation† 4.1 ± 0.6 3.9 ± 0.3 0.35
Physical capacity
UULEX (kg)median (25%-75%)‡ 1 (1 – 1.5) 0.75 (0.5 – 1) 0.08
Endurance testing(s) mean ± standard deviation† 429 ± 156 503 ± 216 0.35
6MWT(m) mean ± standard deviation† 425 ± 85 339 ± 108 0.06
Quality of life
SF-36 PCS (%)mean ± standard deviation† 36 ± 8 36 ± 8 0.99
SF-36 MCS (%)mean ± standard deviation† 44 ± 13 43 ± 13 0.86
Anxiety and Depression
HADS-A (scores)median (25%-75%)‡ 12 (6 – 13) 10 (4 – 14) 0.72
HADS-D (scores) mean ± standard deviation† 10 ± 5 10 ± 3 0.75
*Fisher exat test. †student t test ‡Mann–Whitney U test. PR: Pulmonary Rehabilitation group; CPT: Chest Physical Therapy group; M: Male; F: Female; BMI: Body
Mass Index; COPD: Chronic Obstructive Pulmonary Disease; LC: Lung Cancer; PaO2: Partial pressure of Oxygen in arterial blood; PaCO2: Partial pressure of Carbon
Dioxide in arterial blood; FEV1: Forced Expiratory Volume at the first second; FVC: Forced Vital Capacity; UULEX: unsupported upper limb exercise test; 6MWT:
6-minute Walk Test; PCS: SF-36 Physical Component Summary; MCS: SF-36 Mental Component Summary; HADS-A: Hospital Anxiety and Depression Scale – Anxiety;
HADS-D: Hospital Anxiety and Depression Scale – Depression. Student’s t-test was used for continuous variables and Chi-squared test was used for categorical
variables.
Figure 2 Comparison of serum fibrinogen and albumin levels between pre- and post-intervention in the PR and CPT groups (A and B).
PR group: dotted line; CPT group: continuous line.
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Table 2 Baseline and 1-month physical capacity, quality of life, and anxiety and depression for the twostudy groups
Parameter
Baseline One month
PR (n = 12) CPT (n = 12) PR (n = 12) CPT (n = 12)
Physical capacity
UULEX (kg) mean(SD) 1.13 ± 0.38 0.83 ± 0.39 1.58 ± 0.47 0.88 ± 0.38
Endurance Testing (s) mean(SD) 429 ± 156 503 ± 216 724 ± 202 530 ± 239
Quality of Life
SF-36 PCS (%) mean(SD) 36 ± 8 36 ± 8 44 ± 9 37 ± 7
SF-36MCS (%) mean(SD) 44 ± 13 43 ± 13 49 ± 10 44 ± 11
Anxiety and Depression
HADS-A mean(SD) 10 ± 5 9 ± 6 5 ± 3 8 ± 5
HADS-D mean(SD) 10 ± 5 10 ± 3 5 ± 3 9 ± 3
6MWT(m) mean ± standard deviation 425 ± 85 475 ± 86 339 ± 108 370 ± 120
SD: standard deviation; PR:pulmonary rehabilitation; CPT: chest physical therapy; UULEX: unsupported upper limb exercise test; PCS: SF-36 Physical Component
Summary; MCS: SF-36 Mental Component Summary; HADS-A: Hospital Anxiety and Depression Scale - Anxiety; HADS-D: Hospital Anxiety and Depression
Scale - Depression.
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In the present study, we show that 4 weeks of PR re-
duced serum fibrinogen levels in patients with lung can-
cer and previous inflammatory respiratory disease who
were eligible for lung resection. However, the change in
the albumin levels of this group was not statistically
significant,
As recently as 2006, the ATS and European Respira-
tory Society (ERS) did not mention the effect of PR on
the inflammatory status of patients with LC, in contrast
to studies on inflammation in COPD patients [20]. Sub-
sequently, Jones et al. [21], using a single-group design,
observed that exercise training reduced significantly the
levels of intracellular adhesion molecule-1 among pa-
tients with malignant lung lesions. They also reported
that aerobic training was associated with significant in-
creases in urinary measures of oxidative status in patients
with NSCLC after surgery [22]. In contrast to these pre-
vious studies, we found that serum fibrinogen levels de-
creased after 4 weeks of pulmonary rehabilitation. The
identification of these different biomarkers of systemic in-
flammation among patients with malignant lung lesions is
likely because of the complexity of tumor biology. Further
studies are required to more clearly understand the com-
plex relationship between exercise and tumor biology.
Vogiatzis et al. [23] studied patients with COPD with-
out lung cancer and did not observe changes in the
plasma concentrations of C-reactive protein (CRP), tu-
mor necrosis factor-α, and interleukin-6 after a 10-week
PR program. Pitsavos et al. [24] examined the associ-
ation between physical activity and CRP concentration
in a national sample of the United States population and
observed that physical activity may reduce inflammation.
Most studies on the influence of physical activity on
such blood components are conducted using trained
athletes or athletes undergoing training [24,25], and twopopulation-based studies show that physical activity lo-
wers plasma fibrinogen concentration [26,27]. A large
cross-sectional study of 1284 healthy subjects, with a
mean age of 55.0 ± 13.6 years, showed that fibrinogen
levels decrease with exercise [28]. Similarly, the patients
studied here experienced decreases in plasma fibrinogen
levels.
A study of 635 patients undergoing lung resection has
shown that male gender, preoperative fibrinogen level >
400 mg/dL, and duration of surgery are significantly as-
sociated with pulmonary complications [7]. Because fi-
brinogen levels serve to predict postoperative pulmonary
complications, these data, taken together with our pre-
sent findings, support the conclusion that PR is useful
for lowering serum fibrinogen levels before surgery. More-
over, fibrinogen levels are influenced by other conditions,
such as comorbidities [29] that may have influenced our
results. However, there was a similar distribution of co-
morbidities in the PR and CPT groups (Table 1), which ar-
gues against a bias in the data caused by comorbidities.
There are few studies on the effects of exercise inter-
ventions designed to reduce inflammation in patients
with NSCLC [21,22]. Patients studied here underwent
pulmonary rehabilitation five times a week for 4 weeks.
We were concerned that the 1-month delay in lung re-
section would affect patients’ outcomes. However, the
preoperative protocols employed by the center where
our research was conducted take approximately 1 month
to complete as well.
There are limitations of the present research. For ex-
ample, the number of subjects was small but is similar
to others studies involving exercise and lung cancer. The
study by Jones et al. [21] also observed a significant re-
duction in inflammatory biomarkers after a presurgical
exercise training among 12 patients with lung cancer.
Cesario et al. [30] and Bobbio et al. [31] each evaluated
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observed an improvement in exercise capacity after pul-
monary rehabilitation. Another limitation is the analysis
of only one inflammatory marker. However, fibrinogen
levels can be easily determined in clinical practice, and
they serve as an important a predictor of postoperative
pulmonary complications after lung resection [7]. There
is a potential bias concerning the selection of patients
with previous inflammatory respiratory comorbidities,
which, along with certain therapies such as corticoster-
oid administration and use of bronchodilators, can influ-
ence the reduction of fibrinogen levels. However, after
randomization, the two groups did not differ systematic-
ally at the outset of the study according to the presence
and severity of previous pulmonary disease. Therefore,
we attribute any differences in outcomes to the effects of
the RP and CPT protocols. Another important limitation
is the absence of follow-up of these patients.
Conclusions
A presurgical short-term, high-intensity pulmonary re-
habilitation program reduced serum fibrinogen levels in
patients with NSCLC and previous inflammatory pul-
monary disease. This exploratory study provides prelim-
inary evidence to support the vigorous pursuit of future
studies to investigate the role of exercise in inflamma-
tion and cancer.
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